Evidence map›Paper›PMID 42445841›Full record

ArticleHealth behavior research2026

Kratom Brands in Vape Shops Across the US.

Cassidy R LoParco, Kayla K Tillett, Carla J Berg, Matthew E Rossheim

Abstract read
In one paragraph

Article in Health behavior research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Cassidy R LoParco
Kayla K Tillett
Carla J Berg
Matthew E Rossheim

Funding

Socio-structural determinants of cannabis and derived psychoactive cannabis product use and consequences among young adultsF32DA060612 · NIDA · GEORGE WASHINGTON UNIVERSITY · PI LOPARCO, CASSIDY R · 2024 to 2025
$101k
NIDA NIH HHS F32 DA060612
6 · The paper itself

Abstract

Kratom may pose some health risks (e.g., liver toxicity, seizures, dependence), and interstate commerce is federally illegal; however, kratom is sold widely in the US. The extent of interstate commerce is unclear, but may be indicated by brands present across states/territories. Thus, this study examined kratom brands sold in US vape shops. Using Google Maps, we identified vape shops in all 50 states, DC, and Puerto Rico. Stores were called in November/December 2023. To achieve our target sample of 520 (n=10 per state/territory), 661 stores were called (contact rate=78.7%). Kratom was sold in 372/520 shops (71.5%), of which 153 (41.1%) provided brand information. Among 129 brands reported, OPMS was sold in 90.20% of shops across 42 states/territories, Remarkable Herb in 34.64% across 30 states/territories, and MIT 45 in 33.33% across 31 states/territories. Interstate brand presence indicates likely violations of federal laws and the need to strengthen regulation and enforcement.

Indexed as

brandKratommarketingpolicy

Identifiers

PMID42445841
PMCPMC13361140

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.